未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Hardware-Implemented DropConnect Function for Energy-Efficient Neuromorphic Computing硬件实现的DropConnect函数用于能效神经形态计算
Zhou, JC; Zhang, XW; Zhang, YS; Huang, SM; Chen, AZ; Gong, ZH; Li, ZW; Wang, L; Xue, F; Wang, H; Hu, JY; Li, HX; Xu, Y; Loh, KP; Yu, B 分享 收藏 Influence of Tree Community Characteristics on Carbon Sinks in Urban Parks: A Case Study of Xinyang, ChinaZhang, Honglin; Ren, Qiutan; Zhou, Yuyang; Dong, Nalin; Wang, Hua; Hu, Yongge; Song, Peihao; He, Ruizhen; Tian, Guohang; Ge, Shidong 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 A 3D MCAM architecture based on flash memory enabling binary neural network computing for edge AI基于闪存的3D MCAM架构，可实现边缘AI的二进制神经网络计算Bai, Maoying; Wu, Shuhao; Wang, Hai; Wang, Hua; Feng, Yang; Qi, Yueran; Wang, Chengcheng; Chai, Zheng; Min, Tai; Wu, Jixuan; Zhan, Xuepeng; Chen, Jiezhi 分享 收藏 Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic targetWang, Hua; Tang, Shijie; Wu, Qibiao; He, Yayi; Zhu, Weikang; Xie, Xinyun; Qin, Zhen; Wang, Xue; Zhou, Shiyu; Yao, Shun; Xu, Xiaoling; Guo, Chenchen; Tong, Xinyuan; Han, Shuo; Chou, Yueh-Hung; Wang, Yong; Wong, Kwok-Kin; Yang, Cai-Guang; Chen, Luonan; Hu, Liang; Ji, Hongbin 分享 收藏 Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study新型药物时代诱导治疗的临床结局及高危细胞遗传学异常(HRA)数量对新诊断多发性骨髓瘤(NDMM)患者预后的影响：多中心研究的启示Liang, Dong; Feng, Demei; Wang, Qiaoli; Bai, Shenrui; Zeng, Min; Lu, Bo; Li, Xiaoqing; Sun, Zhiqiang; Li, Jianyun; Zhou, Huanhuan; Zhang, Jialu; Chen, Xiaoqin; Xia, Zhongjun; Liang, Yang; Wang, Hua 分享 收藏 Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II TrialSelinexor联合硼替佐米、来那度胺和地塞米松(XVRd)在高风险初诊多发性骨髓瘤中的安全性与有效性：一项多中心、单臂、Ib/II期临床试验Chen, Xiaoqin; Wang, Yun; Wang, Weida; Wang, Hua; Wu, Bingyi; Liang, Yang; Xia, Zhongjun 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
